Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Weilbaecher

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
NPJ Breast Cancer|January 7, 2023
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, et al.
The Lancet. Oncology|April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trialRebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
Communications Biology|January 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathwaysChristopher Egbulefu, Kvar Black, Xinming Su, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast CancerAndrew A Davis, Jingqin Luo, Tiantian Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
Breast Cancer Research and Treatment|June 26, 2021
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O Ademuyiwa, Ina Chen, Jingqin Luo, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
NPJ Breast Cancer|January 7, 2023
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, et al.
The Lancet. Oncology|April 6, 2010
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trialRebecca Aft, Michael Naughton, Kathryn Trinkaus, et al.
Communications Biology|January 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathwaysChristopher Egbulefu, Kvar Black, Xinming Su, et al.
The Lancet. Oncology|May 1, 2018
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trialSonia Pernas, Miguel Martin, Peter A Kaufman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast CancerAndrew A Davis, Jingqin Luo, Tiantian Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysisAndreas D Hartkopf, Sara Y Brucker, Florin-Andrei Taran, et al.
Breast Cancer Research and Treatment|June 26, 2021
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O Ademuyiwa, Ina Chen, Jingqin Luo, et al.
Pageof 4